Medicare drug benefit package unveiled:
This article was originally published in Clinica
House Republicans unveiled a Medicare prescription drug benefit package for seniors last week that contains a number of items of interest to the medical device industry. The bill includes or expands on provisions contained in the earlier Medicare regulatory and Contracting Reform Act, which passed the US House last year but has been languishing in the US Senate. More details in Clinica No 1013.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.